Soleno Therapeutics Inc (SLNO)

Cost of Revenue

$1.20M

Quarterly · Period ending: · USD

SLNO logo

SLNO Cost of Revenue

Latest reported$1.20M
SLNO Quarterly Cost of Revenue ($0.00 → $1.20M)
High-resolution chart · PNG

SLNO cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
1,198,000
863,000
1,141,000
696,000
0
0
0
494,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
819,847,000
2,689,000
42,000
209,000
222,306
399,000
428,000
461,000
256,683
56,000
22,000
18,000
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.